Advertisement

Reactions Weekly

, Volume 1779, Issue 1, pp 187–187 | Cite as

Pembrolizumab

Various immune therapy related adverse events: 6 case reports
Case report
  • 38 Downloads

Reference

  1. Omar NE-H, et al. Safety of immune checkpoint inhibitors in cancer patients with microsatellite instability-high (MSI-H) status: An experience from Qatar. Journal of the National Comprehensive Cancer Network 17: No. 3, Mar 2019. Available from: URL: http://doi.org/10.6004/jnccn.2018.7142 [abstract] - Qatar

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations